Federal award
CEPHEID
W81K0221P0157
Contract
Obligated and Ceiling
- Obligated (net)
- $1,962,082.73
- Ceiling (potential value, not spending)
- $1,962,082.73
- Current value
- $1,962,082.73
- Gross positive obligations
- $2,113,329.20
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- CEPHEID · W6HQTMWB9Q28
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- DANAHER CORP · C81ZDK1LL4G7
- Awarding agency
- Department of War · sub-agency 97DH · office HT9410
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- W81K0221P0157
- Award type code
- B
- Actions
- 22 · Sep 24, 2021 to Jun 4, 2026
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History22
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Jun 4, 2026 | FY2026 | P00021 | B | $0.00 | — |
| Apr 6, 2026 | FY2026 | P00020 | M | $0.00 | — |
| Mar 19, 2026 | FY2026 | P00019 | M | $0.00 | — |
| Dec 3, 2025 | FY2026 | P00018 | C | $422,629.84 | — |
| Aug 8, 2025 | FY2025 | P00017 | G | $0.00 | — |
| Jul 1, 2025 | FY2025 | P00016 | B | −$65,251.06 | — |
| Dec 3, 2024 | FY2025 | P00015 | M | $0.00 | — |
| Oct 22, 2024 | FY2025 | P00014 | B | $422,629.84 | — |
| May 20, 2024 | FY2024 | P00013 | G | $0.00 | — |
| May 13, 2024 | FY2024 | P00012 | B | −$85,935.41 | — |
| Mar 27, 2024 | FY2024 | P00011 | B | −$60.00 | — |
| Oct 6, 2023 | FY2024 | P00010 | C | $422,689.84 | — |
| Jul 13, 2023 | FY2023 | P00009 | B | $0.00 | — |
| Jun 7, 2023 | FY2023 | P00008 | M | $0.00 | — |
| Jun 5, 2023 | FY2023 | P00007 | M | $0.00 | — |
| May 11, 2023 | FY2023 | P00006 | M | $0.00 | — |
| Oct 19, 2022 | FY2023 | P00005 | M | $422,689.84 | — |
| Jun 29, 2022 | FY2022 | P00004 | B | $25,278.28 | — |
| May 25, 2022 | FY2022 | P00003 | G | $0.00 | — |
| Jan 6, 2022 | FY2022 | P00002 | M | $0.00 | — |
| Oct 13, 2021 | FY2022 | P00001 | C | $397,411.56 | — |
| Sep 24, 2021 | FY2021 | 0 | — | $0.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.